D
Like Score · tier D13qualityScore▲0 · 7d
PriceFree
Reviews24791% positive
Inbound MLT4peers liking this
Lifetime units—no estimate
StatusLiveVery Positive
Sales estimate not available yet
Free-to-play title. Our sales estimator only covers paid games — F2P revenue (mostly DLC + microtransactions) needs a different methodology.
How sales estimation works →01 Like Score
qualityScore = Σ inbound · log₁₀(reviews+1) · positive% · rank-bonus
Tier D · ▲ 0 7d
D ●CBAS
Inbound
4
×
Σ log₁₀(R+1)
10
Avg pos%
92%
→ 13
Score history · 30d retention
8 (14d ago)13 (now)
02 Top inbound contributors
Games whose “More Like This” lists rank XOXO Blood Droplets · 4 inbound · top 4 shown
qualityScore 13
03 XOXO Blood Droplets’s “More like this”
Outbound MLT · 30 games
Review score
8/ 9
% positive
91.5%cohort 71%
Total reviews
247tracked
Velocity · 30d
0 / dayest
Steam-purchase rate
100.0%flat
01 Language distribution
Reviewer interface language · count, share of total, share positive
13 languages · top 12 shown
ENEnglish84.6%20991%
RURussian3.2%888%
ZHSimplified Chinese2.8%7100%
PTBrazilian Portuguese2.0%5100%
FRFrench1.6%4100%
ESSpanish1.6%4100%
DEGerman0.8%2100%
PLPolish0.8%2100%
KOKorean0.8%2100%
JAJapanese0.4%1100%
ESLatin American Spanish0.4%1100%
TRTurkish0.4%1100%
02 Reviews by playtime
Hours played at time of review · positive% per bucket
0-1h 40
75%positive
1-10h 179
94%positive
10-100h 28
96%positive
03 Monthly timeline
Reviews per month · positive vs negative stacked · since launch
Positive 226Negative 21
28211470
19·1020·0621·0222·0122·0923·0624·0525·0626·03
04 Breakdowns
Reviews segmented · count, % of total, % positive
247 reviews
Free product
0/ 247
0.0% of total— no data
Early access
0/ 247
0.0% of total— no data
Key activation
0/ 247
0.0% of total— no data
Steam Deck
0/ 247
0.0% of total— no data
Steam purchase
247/ 247
100.0% of total91% positive
Recommended
226/ 247
91.5% of total— votedUp
Not recommended
21/ 247
8.5% of total— votedDown
Reviews crawled
247/ 247
100.0% of total91% positive
247 reviews · 91% positive
Detailed reviewer overlap is being computed. Check back soon.